Company news
ImmuPharma plc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Trademark Approval
May 13, 2008
Phase IIb Trial of IPP-201101
February 26, 2008
Novel Drug Candidate
January 8, 2008
Initiation of Phase IIb trial
December 6, 2007
Appointment of Nomad
November 16, 2007
Compound Discovery
August 22, 2007
AIM Rule 26
August 20, 2007
Directors' Dealing
August 13, 2007
Pivotal phase II/III trial
July 10, 2007
AGM and Board Update
June 13, 2007
Appointment of adviser
February 15, 2007
Further Phase II Data
October 30, 2006
Phase II Data
October 17, 2006
FDA Meeting on Lupus
October 2, 2006
Start of phase II trial
July 5, 2006
Accounting reference dates
June 12, 2006
Phase 1 Lupus results
May 10, 2006
Research Grants
April 11, 2006
Resignation of NOMAD
October 7, 2004
Temporary Suspension
September 18, 2003
Issue of Convertible Loan
March 28, 2003
Director Shareholding
November 1, 2002
Dir Shareholding - amendment
October 1, 2001
Corporate Action
August 15, 2001
Corporate Action - Update
August 14, 2001
Corporate Action-Replacement
August 13, 2001
Result of AGM & EGM
August 7, 2001
Fthr re Placing & Open Offer
July 13, 2001
Statement re Suspension
June 29, 2001
Additional Funding
June 20, 2001
Funding to Support Expansion
March 27, 2001
Second Interim Results 2000
October 31, 2000
Interim Statement
July 12, 2000
Result of Open Offer
April 19, 2000
Result of EGM
April 18, 2000
Restoration of Trading on AIM
March 27, 2000
Statement re Restoration of Dealing
March 24, 2000
Statement re Suspension of Trading
February 17, 2000
Statement re Share Price Movement
January 18, 2000
Insinger Townsley Appointed as Nominated Broker
November 26, 1999
Calls
Decks
- Investor Presentation (April 2020)
Investor deck · 15 slides · April 2020